Journal
JOURNAL OF CLINICAL EPIDEMIOLOGY
Volume 59, Issue 3, Pages 246-253Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jclinepi.2005.08.015
Keywords
germ cell cancer; prognostic groups; missing data; multiple imputation
Funding
- Medical Research Council [MC_U122861331] Funding Source: researchfish
- MRC [MC_U122861331] Funding Source: UKRI
- Medical Research Council [MC_U122861331] Funding Source: Medline
Ask authors/readers for more resources
Background and Objective: The International Germ Cell Consensus (IGCC) classification defines good, intermediate, and poor prognosis groups among patients with nonseminomatous germ cell cancer. In the database used to develop the IGCC classification (n = 5,202), > 40% of patients were excluded because of missing values (n = 2,154). We looked for effects of this exclusion on survival estimates in the three IGCC prognosis groups. Study Design and Setting: We imputed missing values using a multiple imputation procedure. The IGCC classification was applied to patients with complete data (it = 3,048) and with imputed data (n = 2,154), and 5-year survival was calculated for each prognosis group. Results: Patients with missing values had a lower 5-year survival than those without missing values: 76% vs. 82%. Five-year survival in the complete and imputed data samples was 92% and 87% for the good prognosis groups and 80% and 70% for the intermediate prognosis groups, whereas 5-year survival for the poor prognosis groups in both samples was similar (50% and 47%, respectively). This difference in survival was largely explained by a higher proportion of missing values among patients treated before 1985, who had a worse survival than patients treated after 1985. Conclusion: Multiple imputation of the missing values led to lower survival estimates across the IGCC prognosis groups, compared with estimates based on the complete data. Although imputation of missing values gives statistically better survival estimates, adjustments for year of treatment are necessary to make the estimates applicable to currently diagnosed patients with testicular cancer. (C) 2006 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available